Research reference only. Not medical advice. Most compounds are not FDA-approved. These are research chemicals, not for human consumption. Consult a qualified clinician.Read methodology Terms update on 18 Dec 2026
← Back to Research Index
Compare Evaluate Matrix Half-Life
Dossier · № 73 of 110 Updated Nov 17, 2026

AOD-9604

HGH Fragment 176-191 · AOD9604

PHASE 2B (MIXED) · HGH FRAGMENT; LIPOLYTIC

▓ 16 indexed citations across PubMed (10), EuropePMC (6).

Citation breakdown by evidence tier

← weaker evidence  ·  stronger evidence →

16 citations across 3 tiers

Tap any tier to jump to that section of the bibliography.

Background

AOD9604 is an orally active, lipolytic 16-amino acid peptide fragment of human growth hormone and derivative of the C-terminal domain of human growth hormone (HGH). It consists of HGH residues 176–191, with a tyrosine in place of the phenylalanine at the N-terminal end. Initial human trials showed that it retains the lipolytic properties of human growth hormone without stimulating IGF-1 production. However, later studies failed to demonstrate a sufficient lipolytic effect. Its development was terminated in 2007. Despite its limited efficacy, AOD9604 is still banned in athletes and tested for in competition.

→ Wikipedia

Mechanism of action

Binds β3-adrenergic receptor; stimulates lipolysis without growth-promoting or glucose effects

Researched effects

Lipolysis stimulation; fat loss without IGF-1 rise; no glucose effects

Live evidence

Live signals refreshed daily. Current as of November 19, 2026.

Dosing reported in literature

250 mcg SC daily on empty stomach (Seeds Vol 1 starting dose, range up to 500 mcg/day); 500 mcg oral daily

→ Seeds WA, Peptide Protocols Vol 1 (AOD-9604 AM-fasted starter); r/Peptides wiki AM dosing consensus

Known concerns

Phase 2b failed to show significant weight loss; limited long-term data

Top-ranked picks

10 pre-curated authoritative sources, ranked by journal tier and study weight.

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.

    Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 — REVIEWS · AUTHORITY 54.5

  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

    Sports medicine (Auckland, N.Z.) · 2026 — REVIEWS · AUTHORITY 54.5

  3. AOD-9604 Metabolic.

    Current opinion in investigational drugs (London, England : 2000) · 2004 — REVIEWS · AUTHORITY 52.4

  4. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out mice.

    Endocrinology · 2001 — RESEARCH ARTICLES · AUTHORITY 36.1

  5. Development of Competitive ELISAs Suitable for Detection of Recombinant Human Growth Hormone in Illegal Nutritional Supplements.

    2025 — RESEARCH ARTICLES · AUTHORITY 34.5

  6. Peptides for Targeting Chondrogenic Induction and Cartilage Regeneration in Osteoarthritis.

    2024 — RESEARCH ARTICLES · AUTHORITY 34.4

  7. Naturally derived cytokine peptides limit virus replication and severe disease during influenza A virus infection.

    2023 — RESEARCH ARTICLES · AUTHORITY 34.3

  8. Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS.

    2020 — RESEARCH ARTICLES · AUTHORITY 34.0

  9. Detection and in vitro metabolism of AOD9604.

    Drug testing and analysis · 2015 — RESEARCH ARTICLES · AUTHORITY 33.5

  10. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis Model.

    Annals of clinical and laboratory science · 2015 — RESEARCH ARTICLES · AUTHORITY 33.5

Full citation library

Year distribution

Reviews

3
  1. 1.

    Rahman OF, Lee SJ, Seeds WA · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026 · PMID 41490200

    Therapeutic peptides are emerging as promising adjuncts in the management of orthopaedic injuries, grounded in their ability to modulate molecular signaling networks central to cellular medicine. By acting on key pathways such as PI3K/Akt, mTOR, MAPK, TGF-β, and AMPK, peptides exert influence over tissue regeneration, inflammation resolution, and neuromuscular recovery. Wound-healing peptides such as BPC-157, TB-500, and GHK-Cu promote angiogenesis, integrin-mediated extracellular matrix remodel…

  2. 2.

    Wilding J · Current opinion in investigational drugs (London, England : 2000) · 2004 · PMID 15134286

    Metabolic is developing AOD-9604 for the potential treatment of obesity. By February 2002, phase IIa trials were underway.

  3. 3.

    Mendias CL, Awan TM · Sports medicine (Auckland, N.Z.) · 2026 · PMID 41966639

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside of regulatory oversight. Our objecti…

Research Articles

11
  1. 4.

    Cox HD, Smeal SJ, Hughes CM, Cox JE, et al. · Drug testing and analysis · 2015 · PMID 25208511

    AOD9604 is a peptide consisting of the C-terminal fragment of human growth hormone from amino acids 177-191 with an additional tyrosine residue at the N-terminus of the peptide. It is reported to mimic the lipolytic properties of growth hormone without the diabetogenic side effects. Therefore, AOD9604 may be used as a performance enhancing drug and is banned by the World Anti-doping Agency (WADA). The peptide is available on several Internet websites and was recently identified in confiscated vi…

  2. 5.

    Kwon DR, Park GY · Annals of clinical and laboratory science · 2015 · PMID 26275694

    To investigate the effects of AOD9604 intra-articular injections with or without hyaluronic acid (HA) in a collagenase-induced knee osteoarthritis (OA) rabbit model. Mature New Zealand white rabbits (n=32) were randomly administered 2 mg collagenase type II twice in each knee joint. Weekly injections of 0.6 mL saline (Group 1), 6 mg HA (Group 2), 0.25 mg AOD9604 (Group 3), and 0.25 mg AOD9604 with 6 mg HA (Group 4) were administered for 4-7 weeks after the first intra-articular collagenase injec…

  3. 6.

    Heffernan MA, Thorburn AW, Fam B, Summers R, et al. · International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity · 2001 · PMID 11673763

    To observe the chronic effects of human growth hormone (hGH) and AOD9604 (a C-terminal fragment of hGH) on body weight, energy balance, and substrate oxidation rates in obese (ob/ob) and lean C57BL/6Jmice. In vitro assays were used to confirm whether the effects of AOD9604 are mediated through the hGH receptor, and if this peptide is capable of cell proliferation via the hGH receptor. Obese and lean mice were treated with hGH, AOD or saline for 14 days using mini-osmotic pumps. Body weight, calo…

  4. 7.

    Orlovius AK, Thomas A, Schänzer W, Thevis M · Drug testing and analysis · 2013 · PMID 24124033

  5. 8.

    Ng FM, Sun J, Sharma L, Libinaka R, et al. · Hormone research · 2000 · PMID 11146367

    A synthetic analogue (AOD9604) of the lipolytic domain of human growth hormone (hGH) has been studied for its metabolic actions in obese Zucker rats. Daily treatment with an oral dose of AOD9604 of 500 microg/kg body weight for 19 days reduced over 50% (15.8 +/- 0.6 vs. 35.6 +/- 0.8 g) body weight gain of the animals in comparison with the control. The adipose tissues of the AOD9604--treated animals were found to have an increase in lipolytic activity. In contrast to chronic treatment with intac…

  6. 9.

    Heffernan M, Summers RJ, Thorburn A, Ogru E, et al. · Endocrinology · 2001 · PMID 11713213

    Both human GH (hGH) and a lipolytic fragment (AOD9604) synthesized from its C-terminus are capable of inducing weight loss and increasing lipolytic sensitivity following long-term treatment in mice. One mechanism by which this may occur is through an interaction with the beta-adrenergic pathway, particularly with the beta(3)-adrenergic receptors (beta(3)-AR). Here we describe how hGH and AOD9604 can reduce body weight and body fat in obese mice following 14 d of chronic ip administration. These…

  7. 10.

    Vanhee C, Moens G, Deconinck E, De Beer JO · Drug testing and analysis · 2014 · PMID 24976118

  8. 11.

    Liao HJ, Chen HT, Chang CH. · 2024 · PMID 39291443

    <h4>Objects</h4>Osteoarthritis (OA) is a widespread degenerative joint condition commonly occurring in older adults. Currently, no disease-modifying drugs are available, and safety concerns associated with commonly used traditional medications have been identified. In this review, a significant portion of research in this field is concentrated on cartilage, aiming to discover methods to halt cartilage breakdown or facilitate cartilage repair.<h4>Methods</h4>Researchers have mainly investigated t…

  9. 12.

    Karamonová L, Procházková B, Volný M, Nemeškalová A, Sýkora D, Kuchař M, Fukal L, Holubová B. · 2025 · PMID 40519661

    The use of human growth hormone (hGH) by athletes remains widespread despite being banned by the World Anti-Doping Agency (WADA). Current commercial ELISA kits for the determination of hGH are predominantly based on the sandwich format of this method, which allows the analysis of the whole hGH molecules, but not their fragments. The abuse of these fragments by athletes is the current trend in doping. Therefore, a competitive ELISA format is needed; however, only a limited number of kits on the m…

  10. 13.

    Lange T, Thomas A, Walpurgis K, Thevis M. · 2020 · PMID 32300840

    The added value of dried blood spot (DBS) samples complementing the information obtained from commonly routine doping control matrices is continuously increasing in sports drug testing. In this project, a robotic-assisted non-destructive hematocrit measurement from dried blood spots by near-infrared spectroscopy followed by a fully automated sample preparation including strong cation exchange solid-phase extraction and evaporation enabled the detection of 46 lower molecular mass (< 2 kDa) peptid…

  11. 14.

    Harpur CM, West AC, Le Page MA, Lam M, Hodges C, Oseghale O, Gearing AJ, Tate MD. · 2023 · PMID 36969366

    <h4>Objectives</h4>Novel host-targeted therapeutics could treat severe influenza A virus (IAV) infections, with reduced risk of drug resistance. LAT8881 is a synthetic form of the naturally occurring C-terminal fragment of human growth hormone. Acting independently of the growth hormone receptor, it can reduce inflammation-induced damage and promote tissue repair in an animal model of osteoarthritis. LAT8881 has been assessed in clinical trials for the treatment of obesity and neuropathy and has…

Preprints (not yet peer-reviewed)

2
  1. 15.

    Mendias CL, Awan TM. · 2026

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside regulatory oversight. Our objective…

  2. 16.

    Mendias CL, Awan TM. · 2025

    Peptides are short chains of amino acids with a unique pharmacological niche between small-molecule drugs and large proteins. Their use in sports medicine is rapidly expanding, driven by patient demand for accelerated injury recovery and performance enhancement. While numerous peptide drugs have undergone a rigorous approval process that evaluates both safety and efficacy, a parallel "gray market" of unapproved compounds has emerged, operating largely outside regulatory oversight. Our objective…

Curated sources on file

4
  1. 1.
  2. 2.
  3. 3.
  4. 4.

Continue reading